PRME Prime Medicine Inc Sotuvning yalpi rentabelligi

Prime Medicine Corp (PRME) kompaniyasining rasmiy ramzlari

Yalpi foyda darajalari tebranishlarni namoyish etmoqda, bu esa Prime Medicine, Inc. (PRME) kompaniyasini gen terapiyasi bo'yicha eksklyuziv huquqlarga ega innovator sifatida tasdiqlaydi. Biznes CRISPR tizimlari uchun imkonsiz bo'lgan kam uchraydigan patologiyalarni davolashga tayanadi. Xarajatlarni optimallashtirish testlarni tashqi CRO markazlariga autsorsing qilish orqali amalga oshiriladi. Ushbu tendentsiyada -3.00 ko'rsatkichi maqsadli daraja vazifasini bajarib, kompaniyaning operatsion samaradorligi barqarorligidan dalolat beradi.

Yalpi foyda bo'yicha rentabellik: primemedicine.com (PRME) 28.04.2023 - 20.11.2026 uchun

Prime Medicine (PRME) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:PRME, Prime Medicine Corp
primemedicine.com seriyali mahsuloti

Yalpi foyda marjasi bevosita mahsulot yaratish xarajatlaridan keyin qolgan tushum qismini o'lchash orqali ishlab chiqarish samaradorligini belgilaydi. Bazaviy yalpi foyda marjasining tahlili Prime Medicine, Inc. (PRME) kompaniyasini va uning aniqlikdagi genom tahrirlash sohasidagi ishlanmalarini monetizatsiya qilish qobiliyatini baholash imkonini beradi, bu esa noyob genetik patologiyalar uchun innovatsion davolash usullarini yaratishda daromadli bo'lishni ta'minlash uchun juda muhimdir.

Muhim raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Taysha TSHA|QURE: Yalpi marja|Yalpi foyda bo'yicha rentabellik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Yalpi marja|solidbio.com (SLDB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning yalpi rentabelligi|Benitec Biopharma - Yalpi foyda bo'yicha rentabellik|DSGN: Sotuvning yalpi rentabelligi|RCKT: Yalpi foyda bo'yicha rentabellik|FDMT - Yalpi marja|LXEO: Yalpi marja|Korro Bio Inc. - Yalpi foyda normasi|EDIT (editasmedicine.com) - Yalpi marja|Yalpi rentabellik SLN|Yalpi rentabellik ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning yalpi rentabelligi|Yalpi rentabellik Sangamo SGMO|NAUT: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik